Skip to main content

Search

Reset all filters
1063 Result(s)
Sort by

Our Partners Harvard

Our Partners Harvard

Brock Reeve, Executive Director of the Harvard Stem Cell Institute, talks about the importance of working together to tackle the challenge of fibrosis.
Big hearts united to help animals in Ukraine

Big hearts united to help animals in Ukraine

Veterinaries volunteer at the Polish-Ukrainian border to help welcome Refugees and their animals. Refugees don’t rest until their animals are safe.
Who are we?

Who are we?

Started in 1885 by Albert Boehringer, this independent family-owned company has grown into a top contributor in Human Pharma and Animal Health.
Taking Cancer on at Diagnosis

Taking Cancer on at Diagnosis

We spoke to Markus, Brigitte and Dr Hochmair who shared their advice for people starting their own cancer journeys.
Annual Press Conference 2024

Annual Press Conference 2024

Boehringer Ingelheim presents the 2023 results and an outlook for 2024 at the Annual Press Conference on April 16, 2024.
Speak Up – Compliance Hotline

Speak Up – Compliance Hotline

The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously.
RE-LY-trial-publication-10-year-anniversary

RE-LY-trial-publication-10-year-anniversary

Boehringer Ingelheim recognises the contribution made in the decade since the RE-LY® trial publication by patients, HCPs and researchers
Niha Agarwalla

Niha Agarwalla

My career challenge at Boehringer Ingelheim by Niha Agarwalla. Read it now!
Neovascular AMD (wet AMD)

Neovascular AMD (wet AMD)

Neovascular AMD (or wet AMD) is a severe form of advanced age-related macular degeneration that can lead to irreversible vision loss if untreated